Mirtazapine
Product Images NDC 70518-0316

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 70518-0316). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Mirtazapine 30 mg tablet label from RemedyRepack Inc. The label states a quantity of 30 tablets and includes the NDC number 70518-0316-00. It notes that the tablets are repackaged by RemedyRepack Inc. in Indiana, PA, with manufacturing by Rising Pharma, Inc. The label includes storage instructions and a barcode.*
FDA Label Image

Chemical Structure (Mirtazapine Str)

Chemical Structure (Mirtazapine Str)
Chemical structure diagram of the active ingredient Mirtazapine, showing its fused ring system and methyl substituent. This structural formula represents the molecular arrangement of Mirtazapine.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.